ETC

Recommend
Index
  • Lasix Inj.

    Lasix Inj.

    Ingredient

    Furosemide

    Content

    20mg/2ml

    Indication

    1) Management of edema associated with heart failure (i.e. congestive heart failure), cirrhosis of the liver (i.e. ascites), or renal disease; acute pulmonary edema
    2) Management of essential or renal hypertension

  • Lasix Tab.

    Lasix Tab.

    Ingredient

    Furosemide

    Content

    40mg

    Indication

    Treatment of essential or renal hypertension; cardiac (congestive heart failure), renal, hepatic (ascites) and peripheral vascular edema

  • Megarozet Tab.

    Megarozet Tab.

    Ingredient

    Ezetimibe/Rosuvastatin Calcium

    Content

    10/5mg, 10/10mg, 10/20mg

    Indication

    Treatment of primary hypercholesterolemia: As an adjunct to diet for the reduction of elevated total-C, LDL-C, apolipoprotein-B (apo-B), triglycerides, and non-high-density lipoprotein cholesterol (HDL-C), and to increase HDL-C in patients with primary (heterozygous familial and nonfamilial) hyperlipidemia or mixed hypercholesterolemia

  • Munobal Tab.

    Munobal Tab.

    Ingredient

    Felodipine

    Content

    2.5mg, 5mg

    Indication

    Treatment of hypertension, stable angina pectoris.

  • Opsumit 10mg Tab.

    Opsumit 10mg Tab.

    Ingredient

    Micronized Macitentan

    Content

    10mg

    Indication

    Long-term treatment of pulmonary arterial hypertension (PAH) in adult patients of WHO Functional Class (FC) II to III.
    -Effectiveness was established in patients with idiopathic and heritable PAH, PAH caused by connective tissue disorders, and PAH caused by congenital heart disease.

  • Paxerontine SR Tab. 12.5mg

    Paxerontine SR Tab. 12.5mg

    Ingredient

    Paroxetine Hydrochloride

    Content

    12.5mg

    Indication

    1) Treatment of major depressive disorder
    2) Treatment of panic disorder, with or without agoraphobia
    3) Treatment of social anxiety disorder, also known as social phobia
    4) Treatment of premenstrual dysphoric disorder (PMDD)

  • Paxerontine SR Tab. 25mg

    Paxerontine SR Tab. 25mg

    Ingredient

    Paroxetine Hydrochloride

    Content

    25mg

    Indication

    1) Treatment of major depressive disorder
    2) Treatment of panic disorder, with or without agoraphobia.
    3) Treatment of social anxiety disorder, also known as social phobia.
    4) Treatment of premenstrual dysphoric disorder (PMDD).

  • Relefact LH-RH

    Relefact LH-RH

    Ingredient

    Gonadorelin Acetate

    Content

    0.1mg/1ml (as gonadorelin)

    Indication

    1) Differential diagnosis of infertility
    – Delayed puberty
    – Primary sexual dysfunction as follows: Klinefelter’s syndrome, Turner’s syndrome and Sertoli-Cells-only syndrome.
    – Secondary sexual dysfunction, such as: Kallmann’s syndrome, idiopathic eunuchoidism and Pasqualini’s syndrome
    – Primary amenorrhea
    – Secondary amenorrhea as in anorexia nervosa
    2) Investigation of the location and severity of diseases occurring in the hypothalamic and pituitary gland

  • Roxan Cap.

    Roxan Cap.

    Ingredient

    Roxatidine Acetate Hydrochloride

    Content

    75mg

    Indication

    – gastric and duodenal ulcer
    – reflux esophagitis
    – Zollinger-Ellison syndrome
    – Pre-anesthesia in patients at risk of aspiration of stomach acid (Mendelson’s syndrome), especially pre-anesthesia in delivery
    – Improvement of gastric mucosal lesions (erosion, hemorrhage, redness, edema) of the following diseases: acute exacerbation in acute or chronic gastritis

  • Rulid Pediatric Dispersed Tab. 50mg

    Rulid Pediatric Dispersed Tab. 50mg

    Ingredient

    Roxithromycin Coated

    Content

    Roxithromycin Coated 77mg (50mg as Roxithromycin)

    Indication

    Effective Species: Streptococcus, Streptococcus pneumonia, Neisseria meningitidis, Neisseria gonorrhoeae, Bordetella pertussis, bacteria cocci associated with catarrh, Corynebacterium diphtheria, Clostridium perfringens, Mycoplasma pneumonia, Chlamydia trachomatis, Ureaplasma urealyticum, Legionella pneumophila, Campylobacter pylori, Campylobacter jejuni, Gardnerella vaginalis, Haemophilus influenza, Staphylococcus aureus, Vibrio cholera, and Chlamydia psittaci
    Indications:
    – respiratory infectious disease: pharyngolaryngitis, acute bronchitis, tonsillitis, bacterial pneumonia, mycoplasma pneumonia, etc.
    – genital infections and sexually transmitted diseases, excluding infection by Neisseria gonorrhoeae
    – otitis media and sinusitis
    – folliculitis, furuncle, furunculosis, carbuncle, erysipelas, cellulitis, lymphangitis(lymphadenitis), whitlow, purulent paronychia, subcutaneous abscess, hidradenitis, acne conglobate, and infectious atheroma
    – prophylaxis of infection in case of contact with meningococcal meningitis patients
    – pericoronitis and periodontitis

TOP